Literature DB >> 10645408

Expression of human papillomavirus E7 mRNA in human oral and cervical neoplasia and cell lines.

L D Ke1, K Adler-Storthz, M F Mitchell, G L Clayman, Z Chen.   

Abstract

Human papillomaviruses (HPVs) have been strongly linked to progression of human cancers, such as cervical and oral cancers. Two HPV oncoproteins, E6 and E7, can inhibit the tumor suppressor proteins, p53 and pRB, respectively, resulting in a deregulation of the cell cycle. In order to further test the significance of HPV expression in oral and cervical carcinogenesis, we analyzed HPV E7 mRNA in oral and cervical neoplasia and cell lines by reverse transcriptase-polymerase chain reaction (RT-PCR). We found that HPV E7 mRNA was present in 90% of patients with oral neoplasia and 100% of patients with cervical neoplasia. Quantitative RT-PCR and western blot analysis on both transformed cervical and oral epithelial cell lines demonstrated that the mRNA level of HPV-16 E7 corresponded to E7 protein level, suggesting that HPV oncogene expression is primarily regulated at the transcriptional or post-transcription level. The potential clinical application of quantitative RT-PCR for HPV E7 mRNA expression in cancer screening and treatment evaluation requires further investigation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10645408     DOI: 10.1016/s1368-8375(99)00015-9

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  7 in total

Review 1.  Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination.

Authors:  Maura L Gillison
Journal:  J Adolesc Health       Date:  2008-10       Impact factor: 5.012

2.  Human papillomavirus type 16 E7 oncoprotein represses transcription of human fibronectin.

Authors:  O Rey; S Lee; N H Park
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

Review 3.  Evidence for a causal association for HPV in head and neck cancers.

Authors:  H H Sudhoff; H P Schwarze; D Winder; L Steinstraesser; Martin Görner; M Stanley; P K C Goon
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-07-27       Impact factor: 2.503

Review 4.  Clinical implications of human papillomavirus in head and neck cancers.

Authors:  Carole Fakhry; Maura L Gillison
Journal:  J Clin Oncol       Date:  2006-06-10       Impact factor: 44.544

5.  An AP-1 binding site mutation in HPV-16 LCR enhances E6/E7 promoter activity in human oral epithelial cells.

Authors:  Yanna Liu; Jun Z Li; Xiao H Yuan; Karen Adler-Storthz; Zhuo Che
Journal:  Virus Genes       Date:  2002       Impact factor: 2.332

6.  Human papillomavirus 6/11, 16 and 18 in oral carcinomas and benign oral lesions.

Authors:  Christiane Ostwald; Karin Rutsatz; Jens Schweder; Wolfgang Schmidt; Karsten Gundlach; Malte Barten
Journal:  Med Microbiol Immunol       Date:  2002-11-01       Impact factor: 3.402

7.  Absolute quantitative real-time polymerase chain reaction for the measurement of human papillomavirus E7 mRNA in cervical cytobrush specimens.

Authors:  Michael E Scheurer; Laura M Dillon; Zhuo Chen; Michele Follen; Karen Adler-Storthz
Journal:  Infect Agent Cancer       Date:  2007-04-02       Impact factor: 2.965

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.